Search | Page 28 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Biting into the Elephant

    ... azacitidine (Vidaza®) treatment followed by a stem cell transplant . I received the gift of life from my brother Neal on ...

    Patient Chronicle last updated 06/27/2016 - 2:22pm.

  2. Dr. Vivienne Rebel reports on a study of the relationship between gene mutations and overall survival after stem cell transplant

    ... patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. Original ...

    Research Review last updated 05/02/2016 - 9:16am.

  3. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... with hematologic malignancies undergoing hematopoietic stem cell transplant (HSCT). Biological therapies, such as sirolimus and ...

    Clinical Trial last updated 05/03/2016 - 11:35am.

  4. Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    ... with fludarabine and cladribine before a stem cell transplant in patients with AML or MDS may help to control the ...

    Clinical Trial last updated 04/28/2016 - 3:41pm.

  5. Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

    ... patients with hematologic malignancies undergoing donor stem cell transplant . Vaccines made from a peptide may help the body build an ...

    Clinical Trial last updated 04/29/2016 - 2:03pm.

  6. AML Therapy With Irradiated Allogeneic Cells

    ... must not be a candidate for an allo-hematopoietic stem cell transplant (HSCT) Patient must have a partially (>= 3/6 class I ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  7. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy , such as azacitidine , ... patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  8. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... of the blood and immune system is to give a patient stem cells from the bone marrow of a donor whose genes are very ... system to recover in a way that improves white blood cell function. In this study they will be looking at the drug lupron, a ...

    Clinical Trial last updated 04/28/2016 - 11:14am.

  9. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  10. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... chemotherapy and/or arising from MDS, Langerhan's cell histiocytosis, any disease beyond first remission; or, Myelodysplastic ... relapse (including relapse post autologous hematopoietic stem cell transplant ). Double hit lymphomas in first remission or more ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.